The Indiana Department of Health (IDOH) announced today that a total of 45 monkeypox cases have been reported across the state between June 18 and July 28, including two pediatric cases. No additional information about the cases will be released at this time due to patient privacy.
To date, Indiana has received 3,232 doses of Jynneos vaccine. Due to limited vaccine supply, vaccines are initially being prioritized for close contacts of positive cases to prevent severe disease. Additional vaccine is expected soon, and eligibility will be expanded to groups at high risk for exposure as supplies increase.
“Like many other states, Indiana has seen an increase in monkeypox cases over the past month,” said State Health Commissioner Kris Box, M.D., FACOG. “Monkeypox does not easily spread through brief casual contact, but it’s important to remember that anyone can be affected if they are a close contact of a positive case. Hoosiers who believe they may have been exposed or who develop symptoms consistent with monkeypox are urged to contact a healthcare provider.”
Monkeypox is a rare disease caused by infection with the monkeypox virus, which is part of the same family of viruses as smallpox. Symptoms are similar to smallpox, but milder, and monkeypox is rarely fatal. The illness typically begins with fever, headache, chills, muscle aches and exhaustion about five to 21 days after exposure. Within one to three days (sometimes longer) after the appearance of fever, the patient develops a rash. The rash may start in the mouth or any part of the body before spreading. Some people may only develop the rash. The illness typically lasts for two to four weeks. People are considered infectious until all scabs from the rash have fallen off and a fresh layer of skin has formed.
Person-to-person transmission is possible either through skin-to-skin contact with body fluids, monkeypox sores or contaminated items, such as bedding or clothing, or through exposure to respiratory droplets during prolonged face-to-face contact.